Endocrinology, Vol 125, 2719-2727, Copyright © 1989 by Endocrine Society

ARTICLES

Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen

SM Chang and LW Chung
Department of Urology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.

We have established and characterized two cell lines from the ventral prostate gland of normal Nb rats: NbE-1 (prostatic epithelial) and NbF- 1 (prostatic fibroblast) cell lines. To identify the direct mitogenic action of dihydrotestosterone (DHT), we incubated these cell lines alone and together (in the presence and absence of cell contact) with various concentrations of DHT (0.1-10,000 ng/ml) for 24-72 h and assayed for the rate of DNA synthesis and the total number of cells in tissue culture at specified time periods. Results demonstrate that the primary target for DHT mitogenic action is the prostatic fibroblasts. DHT inhibited the growth of prostatic epithelial cells by themselves, but stimulated prostatic epithelial cell growth when the epithelial cells were cocultured with prostatic fibroblasts. Furthermore, the cell- conditioned medium obtained from either the fibroblast or the epithelial cells stimulated in an autocrine or a paracrine manner the growth of prostatic cells in culture. These results are consistent with the concept that DHT stimulates the growth of prostatic epithelial cells indirectly via its direct mitogenic action on the prostatic fibroblasts. Because epithelial cells are the cell type principally responsible for converting testosterone to DHT, and the fibroblasts respond to the mitogenic action of DHT, our results support the concept that tight metabolic cooperation exists between prostatic epithelial and fibroblast cells. These data are in agreement with previous in vivo studies in which we have demonstrated that androgen receptors in the mesenchyme are obligatory for androgen-induced prostate growth and development.

This article has been cited by other articles:

				P. Cano, A. Godoy, R. Escamilla, R. Dhir, and S. A. Onate Stromal-Epithelial Cell Interactions and Androgen Receptor-Coregulator Recruitment Is Altered in the Tissue Microenvironment of Prostate Cancer Cancer Res., January 15, 2007; 67(2): 511 - 519. [Abstract] [Full Text] [PDF]

				S.-M. Ho, W.-Y. Tang, J. Belmonte de Frausto, and G. S. Prins Developmental Exposure to Estradiol and Bisphenol A Increases Susceptibility to Prostate Carcinogenesis and Epigenetically Regulates Phosphodiesterase Type 4 Variant 4 Cancer Res., June 1, 2006; 66(11): 5624 - 5632. [Abstract] [Full Text] [PDF]

				D. J. Lamb and L. Zhang Challenges in Prostate Cancer Research: Animal Models for Nutritional Studies of Chemoprevention and Disease Progression J. Nutr., December 1, 2005; 135(12): 3009S - 3015S. [Abstract] [Full Text] [PDF]

				J. D. Anderson, T. P. Hansen, P. W. Lenkowski, A. M. Walls, I. M. Choudhury, H. A. Schenck, M. Friehling, G. M. Holl, M. K. Patel, R. A. Sikes, et al. Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3 Mol. Cancer Ther., November 1, 2003; 2(11): 1149 - 1154. [Abstract] [Full Text] [PDF]

				T. H. Ngo, R. J. Barnard, P.-S. Leung, P. Cohen, and W. J. Aronson Insulin-Like Growth Factor I (IGF-I) and IGF Binding Protein-1 Modulate Prostate Cancer Cell Growth and Apoptosis: Possible Mediators for the Effects of Diet and Exercise on Cancer Cell Survival Endocrinology, June 1, 2003; 144(6): 2319 - 2324. [Abstract] [Full Text] [PDF]

				M. V. Maffini, P. Geck, C. E. Powell, C. Sonnenschein, and A. M. Soto Mechanism of Androgen Action on Cell Proliferation: AS3 Protein as a Mediator of Proliferative Arrest in the Rat Prostate Endocrinology, July 1, 2002; 143(7): 2708 - 2714. [Abstract] [Full Text] [PDF]

				K.-i. Nakashiro, M. Okamoto, Y. Hayashi, and R. Oyasu Hepatocyte Growth Factor Secreted by Prostate-Derived Stromal Cells Stimulates Growth of Androgen-Independent Human Prostatic Carcinoma Cells Am. J. Pathol., September 1, 2000; 157(3): 795 - 803. [Abstract] [Full Text] [PDF]

				J. L. Holleran, C. J. Miller, and L. A. Culp Tracking Micrometastasis to Multiple Organs with lacZ-tagged CWR22R Prostate Carcinoma Cells J. Histochem. Cytochem., May 1, 2000; 48(5): 643 - 652. [Abstract] [Full Text]

				T. J. Ahonen, P. L. Härkönen, J. Laine, H. Rui, P. M. Martikainen, and M. T. Nevalainen Prolactin Is a Survival Factor for Androgen-Deprived Rat Dorsal and Lateral Prostate Epithelium in Organ Culture Endocrinology, November 1, 1999; 140(11): 5412 - 5421. [Abstract] [Full Text]

				G. N. Thalmann, R. A. Sikes, R. E. Devoll, J. A. Kiefer, R. Markwalder, I. Klima, C. M. Farach-Carson, U. E. Studer, and L. W. K. Chung Osteopontin: Possible Role in Prostate Cancer Progression Clin. Cancer Res., August 1, 1999; 5(8): 2271 - 2277. [Abstract] [Full Text] [PDF]

				A. Degeorges, F. Wang, H. F. Frierson Jr., A. Seth, L. W. K. Chung, and R. A. Sikes Human Prostate Cancer Expresses the Low Affinity Insulin-like Growth Factor Binding Protein IGFBP-rP1 Cancer Res., June 1, 1999; 59(12): 2787 - 2790. [Abstract] [Full Text] [PDF]

				C. M. Butler,, J. L. Harry,, J. E. Deakin,, D. W. Cooper,, and M. B. Renfree Developmental Expression of the Androgen Receptor during Virilization of the Urogenital System of a Marsupial Biol Reprod, October 1, 1998; 59(4): 725 - 732. [Abstract] [Full Text]

				M. E. Chen, S.-H. Lin, L. W. K. Chung, and R. A. Sikes Isolation and Characterization of PAGE-1 and GAGE-7. NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS J. Biol. Chem., July 10, 1998; 273(28): 17618 - 17625. [Abstract] [Full Text] [PDF]

				E. Levesque, M. Beaulieu, C. Guillemette, D. W. Hum, and A. Belanger Effect of Interleukins on UGT2B15 and UGT2B17 Steroid Uridine Diphosphate-Glucuronosyltransferase Expression and Activity in the LNCaP Cell Line Endocrinology, May 1, 1998; 139(5): 2375 - 2381. [Abstract] [Full Text] [PDF]

				C. W. Bayne, F. Donnelly, K. Chapman, P. Bollina, C. Buck, and F. K. Habib A Novel Coculture Model for Benign Prostatic Hyperplasia Expressing Both Isoforms of 5{alpha}-Reductase J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 206 - 213. [Abstract] [Full Text]